Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.65 Billion | 1.42 Billion | 1.45 Billion | 1.55 Billion | 1.55 Billion | 1.27 Billion |
| Cost of Revenue | 945 Million | 860.01 Million | 839.91 Million | 867.65 Million | 1 Billion | 654.41 Million |
| Gross Profit | 708.08 Million | 566.32 Million | 619.86 Million | 691.81 Million | 550.74 Million | 620.4 Million |
| Operating Expenses | 645 Million | 678.03 Million | 579.28 Million | 543.44 Million | 647.67 Million | 538.16 Million |
| Selling, General and Administrative Expenses | 604 Million | 159.04 Million | 136.81 Million | 114.84 Million | 200.88 Million | 510.34 Million |
| Research and Development Expenses | 41 Million | 42.64 Million | 8.06 Million | 20.41 Million | 32.06 Million | 34.87 Million |
| Other Expenses | - | 476.34 Million | 434.4 Million | 408.18 Million | 414.73 Million | 7.06 Million |
| Cost and Expenses | 1.59 Billion | 1.53 Billion | 1.41 Billion | 1.41 Billion | 1.64 Billion | 654.41 Million |
| Operating Income | 89.39 Million | -111.7 Million | 43.92 Million | 153.17 Million | -96.92 Million | 620.4 Million |
| Interest Expense | 59.23 Million | 35.3 Million | 31.4 Million | 33.43 Million | 41.03 Million | - |
| Income Tax Expense | 45.26 Million | 24.98 Million | 12.34 Million | 43.89 Million | 31.67 Million | -90.19 Million |
| Earnings before Tax | 36.18 Million | -145.24 Million | 33.72 Million | 157.97 Million | -449.39 Million | 12.63 Million |
| Net Income | -13.71 Million | -170.23 Million | 26.45 Million | 124.78 Million | -481.07 Million | 102.82 Million |
| Earnings Per Share Basic | -0.11 | -1.42 | 0.22 | 1.04 | -4.01 | 0.86 |
| Earnings Per Share Diluted | -0.11 | -1.42 | 0.22 | 1.04 | -4.01 | 0.86 |
| Weighted Average Shares Outstanding | 119.96 Million | 120 Million | 120 Million | 120 Million | 120 Million | 120 Million |
| Weighted Average Shares Outstanding (Diluted) | 119.96 Million | 120 Million | 120 Million | 120 Million | 120 Million | 120 Million |
| Gross Margin | 0.43 | 0.40 | 0.42 | 0.44 | 0.35 | 0.49 |
| EBIT Margin | 0.09 | -0.01 | 0.09 | 0.18 | -0.14 | 0.03 |
| Profit Margin | -0.01 | -0.12 | 0.02 | 0.08 | -0.31 | 0.08 |
| EBITDA | 153.97 Million | -13.46 Million | 142.64 Million | 241.95 Million | -290.93 Million | 162.56 Million |
| Earnings Before Tax Margin | 0.05 | -0.08 | 0.03 | 0.10 | -0.06 | 0.49 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 373.37 Million | 475 Million | 1.65 Billion | 331 Million | 381.62 Million | 408.72 Million |
| Cost of Revenue | 195.97 Million | 223 Million | 945 Million | 229 Million | 215.64 Million | 225.23 Million |
| Gross Profit | 177.4 Million | 252 Million | 708 Million | 102 Million | 165.97 Million | 183.49 Million |
| Operating Expenses | 146.8 Million | 165 Million | 645 Million | 164 Million | 157.87 Million | 148.97 Million |
| Selling, General and Administrative Expenses | 133.55 Million | 148 Million | - | 154 Million | 150.37 Million | 137.93 Million |
| Research and Development Expenses | 13.25 Million | 17 Million | - | 10 Million | 7.5 Million | 11.04 Million |
| Other Expenses | 5.35 Million | -1 Million | 37.32 Million | 33.06 Million | -28.94 Million | 1.41 Million |
| Cost and Expenses | 342.78 Million | 388 Million | 1.59 Billion | 393 Million | 373.52 Million | 374.2 Million |
| Operating Income | 30.59 Million | 87 Million | 63 Million | -62 Million | -16.59 Million | 35.08 Million |
| Interest Expense | 13.11 Million | 12 Million | 59.23 Million | 7.76 Million | 24.15 Million | 15.74 Million |
| Income Tax Expense | -767 Thousand | 7 Million | 45 Million | 29 Million | 4.37 Million | 3.12 Million |
| Earnings before Tax | 25.58 Million | 46 Million | 36 Million | -21 Million | -34.02 Million | 25.1 Million |
| Net Income | 33.11 Million | 35.6 Million | -3 Million | -43 Million | -40.97 Million | 22.29 Million |
| Earnings Per Share Basic | 0.28 | 0.33 | - | -0.36 | -0.34 | 0.19 |
| Earnings Per Share Diluted | 0.28 | 0.33 | - | -0.36 | -0.34 | 0.19 |
| Weighted Average Shares Outstanding | 119.72 Million | 119.75 Million | 119.96 Million | 119.75 Million | 120 Million | 120 Million |
| Weighted Average Shares Outstanding (Diluted) | 119.72 Million | 119.75 Million | 119.96 Million | 119.75 Million | 120 Million | 120 Million |
| Gross Margin | 0.48 | 0.53 | 0.43 | 0.31 | 0.43 | 0.45 |
| EBIT Margin | 0.14 | 0.23 | - | -0.14 | 0.02 | 0.15 |
| Profit Margin | 0.09 | 0.07 | -0.00 | -0.13 | -0.11 | 0.05 |
| EBITDA | 51.67 Million | 107 Million | - | -45 Million | 5.82 Million | 62.26 Million |
| Earnings Before Tax Margin | 0.08 | 0.18 | 0.04 | -0.19 | -0.04 | 0.09 |
002063
ATLN
GMVHF
CTOC
GET
VEON